Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells
Open accessThe DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index; 45 of the 212 sources its claims cite were checked for support.
Abstract
Bone tissue is continuously remodeled through the concerted actions of bone cells, which include bone resorption by osteoclasts and bone formation by osteoblasts, whereas osteocytes act as mechanosensors and orchestrators of the bone remodeling process. This process is under the control of local (e.g., growth factors and cytokines) and systemic (e.g., calcitonin and estrogens) factors that all together contribute for bone homeostasis. An imbalance between bone resorption and formation can result in bone diseases including osteoporosis. Recently, it has been recognized that, during bone remodeling, there are an intricate communication among bone cells. For instance, the coupling from bone resorption to bone formation is achieved by interaction between osteoclasts and osteoblasts. Moreover, osteocytes produce factors that influence osteoblast and osteoclast activities, whereas osteocyte apoptosis is followed by osteoclastic bone resorption. The increasing knowledge about the structure and functions of bone cells contributed to a better understanding of bone biology. It has been suggested that there is a complex communication between bone cells and other organs, indicating the dynamic nature of bone tissue. In this review, we discuss the current data about the structure and functions of bone cells and the factors that influence bone remodeling.
Overview
CoChat Summary
TL;DR
This narrative review summarizes bone tissue biology, focusing on the structure and functions of osteoblasts, bone lining cells, osteocytes, and osteoclasts, the extracellular matrix, and local/systemic regulators of bone remodeling. It emphasizes cell–cell coupling, osteocyte mechanosensing, estrogen’s role, and emerging endocrine functions of bone.
Key findings
- Bone contains four cell types: osteoblasts (4–6% of total resident bone cells) form bone; osteocytes (90–95% of total bone cells, lifespan up to 25 years) act as mechanosensors and orchestrators; osteoclasts resorb bone; bone lining cells participate in coupling and the basic multicellular unit.
- The osteocyte lacunocanalicular system includes up to 50 cytoplasmic processes per cell; osteocyte surface is estimated to be 400-fold larger than all Haversian and Volkmann systems and more than 100-fold larger than trabecular bone surface; the lacunar space is about 0.5–1.0 μm wide and the canalicular membrane distance is 50–100 nm.
- Bone remodeling proceeds through initiation of resorption, a transition/reversal phase, and bone formation; coupling involves matrix-released factors such as IGFs, TGF-β, BMPs, FGF, and PDGF, plus semaphorins (Sema4D, Sema3A) and ephrinB2/EphB4, while imbalance can cause osteoporosis or osteopetrosis.
- Estrogen maintains bone homeostasis by inhibiting osteoblast and osteocyte apoptosis, suppressing osteoclast formation/activity, inducing osteoclast apoptosis, and modulating RANKL/OPG and cytokines; bone endocrine actions include undercarboxylated osteocalcin effects on pancreas, adipose tissue, testis, and brain, and osteocyte FGF23 regulation of phosphate metabolism.
Methods
- Design: narrative review; the authors state they discuss current data about bone cells, bone matrix, factors influencing bone remodeling, and estrogen under physiological and pathological conditions.
- Data or sample: no primary sample or dataset; evidence is drawn from cited in vitro and in vivo studies and prior literature.
- Main analysis: narrative synthesis of structural, molecular, and functional findings; no systematic search, meta-analysis, or new experiments are reported.
Limitations
- Stated in the paper: bone lining cell functions are not completely understood; mechanisms of osteocyte mechanosensing and the precise osteocyte-derived osteoclastogenesis-stimulating factors remain uncertain; direct in vivo contact between mature osteoblasts and osteoclasts has not been demonstrated and is controversial; bone endocrine function is still poorly understood.
- Evident from the text: as a narrative review, it lacks a systematic search strategy, risk-of-bias assessment, or quantitative synthesis, and its conclusions depend on the selected cited literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
23 Valid · 2 Not valid · 92 Not checked · 16 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“For instance, in bones subjected to fatigue loading, viable osteocytes near the apoptotic ones express, besides high RANKL/OPG ratio, increased levels of vascular endothelial growth factor (VEGF) and monocyte chemoattractant protein-1 (CCL2) promoting an increase in local osteoclastogenesis [194, 195].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.8. Bone Remodeling Process
What the sources say
- Partly supportedcites [194] matched to “Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations” (2012) sourceExperimental — accuracy not yet measured
Kennedy et al. (2012) support most of the sentence: the Abstract (p.1) and Results > Immunohistochemistry show RANKL and VEGF staining peaking 100-300 um from the damage site in non-apoptotic osteocytes while caspase-3+ cells dominate the damage core, and the Discussion states the RANKL/OPG ratio shift 'favoring osteoclast formation'. However, the candidate genes and IHC targets were only RANKL, OPG, VEGF and M-CSF (Materials and Methods > Gene expression analyses; Results > Gene expression) - CCL2/MCP-1 is neither measured nor mentioned anywhere in our copy (searched: CCL2, monocyte chemoattractant protein-1, MCP-1, chemokine), so that part of the claim is not attributable to this source. Also, the pro-osteoclastogenic conclusion is inferred from signaling patterns, since tissues were analyzed 3 and 7 days after fatigue, 'prior to the first appearance of osteoclasts'. (LLM, conf=0.85)
- Disputedcites [195] matched to “MCP-1 Expression Is Specifically Regulated During Activation of Skeletal Repair and Remodeling” (2013) sourceExperimental — accuracy not yet measured
Our copy places CCL2/MCP-1 expression in osteoblasts, not osteocytes: the Abstract reports that by in-situ hybridization and immunohistochemistry 'MCP-1 mRNA and protein was localized in periosteal osteoblasts associated with woven bone formation at the fracture exit point, but not within osteocytes adjacent to the SFx', and the Discussion likewise concludes MCP-1 is secreted by osteoblasts as a candidate signal attracting osteoclasts and their precursors. The paper's model is rat ulnar stress fracture initiation by cyclic end-loading, and it explicitly contrasts this with 'adaptive' ulnar loading; nowhere does our copy report viable osteocytes near apoptotic ones, nor any measurement of VEGF or of a high RANKL/OPG ratio in osteocytes (RANKL/OPG appears only as a downstream pathway shared with gp-130 cytokines such as IL-6/IL-11, Discussion). Thus the cellular source and the VEGF/RANKL-OPG components attributed to this source are contrary to, or absent from, our copy. (LLM, conf=0.80)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
None of the sources cited for this claim have been checked yet.
In the paper
“Bone lining cells functions are not completely understood, but it has been shown that these cells prevent the direct interaction between osteoclasts and bone matrix, when bone resorption should not occur, and also participate in osteoclast differentiation, producing osteoprotegerin (OPG) and the receptor activator of nuclear factor kappa-B ligand (RANKL) [14, 53].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.2. Bone Lining Cells
What the sources say
- Could not verifycites [14] matched to “A Physical Mechanism for Coupling Bone Resorption and Formation in Adult Human Bone” (2009) sourceExperimental — accuracy not yet measured
The Discussion describes bone-lining cells as poorly characterized and suggests they may be early osteoblast-lineage cells. It separately suggests that osteoblast precursors near differentiating pre-osteoclasts may express RANKL, but does not identify those precursors as bone-lining cells or say that bone-lining cells produce OPG. Searches for bone-lining cells with OPG, RANKL, and osteoclast differentiation found no passage establishing the claim. (LLM, conf=0.73)
- Not checked yetcites [53] 2000, Journal of Rehabilitation Research and Development
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Moreover, osteocyte apoptosis has been recognized as a chemotactic signal to osteoclastic bone resorption [70–73].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.3. Osteocytes
What the sources say
- Not checked yetcites [70] matched to “Identification of apoptotic changes in osteocytes in normal and pathological human bone” (1997) source
- Not checked yetcites [71] matched to “Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss.” (2006) source
- Supportedcites [72] matched to “Apoptotic Osteocytes and the Control of Targeted Bone Resorption” (2014) source
The section on osteocyte apoptosis and osteoclast recruitment states that apoptotic osteocytes recruit osteoclasts to initiate bone resorption. It also identifies HMGB1, released by apoptotic osteocytic cells, as chemotactic for osteoclasts, while noting that the signals responsible in vivo remain to be identified. (LLM, conf=0.86)
- Supportedcites [73] matched to “Osteocyte-Driven Bone Remodeling” (2014) source
In section 3, “Dying osteocytes,” the review says apoptotic osteocytes precede resorption and may act as beacons for osteoclast recruitment. It also describes a potential chemotactic factor released during osteocyte apoptosis. The claim reflects that proposed link without identifying a specific signal. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Other recent evidence is that osteoclasts may also directly regulate the hematopoietic stem cell niche [112].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.4. Osteoclasts
What the sources say
- Supportedcites [112] matched to “Osteoclasts: more than ‘bone eaters’” (2014) source
The HSC-niche section says osteoclasts may directly regulate the hematopoietic stem cell niche. The Concluding Remarks repeat this qualified claim while noting that conflicting reports remain to be resolved. (LLM, conf=0.95)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The systemic factors which are important to the maintenance of bone homeostasis include parathyroid hormone (PTH), calcitonin, 1,25-dihydroxyvitamin D3 (calcitriol), glucocorticoids, androgens, and estrogens [16, 147–150].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.7. Local and Systemic Factor That Regulate Bone Homeostasis
What the sources say
- Partly supportedcites [16] matched to “Estrogen and the skeleton” (2012) sourceExperimental — accuracy not yet measured
Our copy supports only the sex-steroid part of the attributed list: the Overview of estrogen action on bone states that 'estrogen is perhaps the major systemic regulator of bone metabolism not only in women, but also in men,' and the same section (citing Falahati-Nini et al., ref 5) and ref 31 address androgens/testosterone as systemic bone regulators. The other four factors named in the claim — parathyroid hormone, calcitonin, 1,25-dihydroxyvitamin D3 (calcitriol) and glucocorticoids — appear nowhere in our copy (searched: 'systemic factors parathyroid hormone calcitonin 1,25-dihydroxyvitamin D glucocorticoids', 'parathyroid hormone', 'calcitonin', 'glucocorticoids calcitonin vitamin D androgens'); every returned passage concerned estrogen actions, coupling factors in the bone remodeling compartment, or the reference list. Thus the paper does not enumerate the systemic hormonal repertoire the citing sentence attributes to it. (LLM, conf=0.72)
- Partly supportedcites [147] matched to “Activated parathyroid hormone/parathyroid hormone–related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone” (2001) sourceExperimental — accuracy not yet measured
The Introduction (p. 1) of Calvi et al. 2001 supports only the PTH element of the list: it describes PTH as 'a major regulator of calcium homeostasis' that 'plays an important role in both bone formation and resorption' in the context of factors controlling osteoblast/osteoclast balance. Our copy nowhere mentions calcitonin, 1,25-dihydroxyvitamin D3 (calcitriol), glucocorticoids, androgens, or estrogens as systemic factors maintaining bone homeostasis (searched: calcitonin; estrogen/glucocorticoid/systemic hormonal regulators; 1,25-dihydroxyvitamin D3), so the remaining five items attributed to this source are unsupported. The paper's scope is the local action of activated PTH/PTHrP receptor in osteoblastic cells on cortical versus trabecular bone in transgenic mice, not a survey of systemic hormonal regulators. (LLM, conf=0.72)
- Not checked yetcites [148] 2002, BMC Musculoskeletal Disorders
- Not checked yetcites [149] matched to “Forty years of calcitonin—where are we now? A tribute to the work of Iain Macintyre, FRS” (2002) source
- Not checked yetcites [150] matched to “Androgens and Bone” (2004) source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 12 with their cited sources checked
Create a free account to see all 133 claims and to verify the 167 references still open.
- It may state two separate claims as one. 40
- Probably not a substantial claim. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vivo, a set of osteoblasts, all with similar morphologies, lay down osteoid on active bone-forming surfaces.268”
From Bone remodeling: an operational process ensuring survival and bone mechanical competence (2022) · cites this paper as [268]
Citations
Cites
Stöckl, S., Göttl, C., Grifka, J., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,656
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80257-3 · Cited by 4,246 · cited 2×
“The expressions of Runtrelated transcription factors 2,Distal-less homeobox 5 (Dlx5), and osterix (Osx) are crucial for osteoblast differentiation [22, 26].”
BackgroundKomori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y.-H., Inada, M., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80258-5 · Cited by 4,244
Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287 · cited 3×
“Besides osteoclasts and osteoblasts, it has been demonstrated that osteocytes play key roles during the bone remodeling cycle [8].”
BackgroundNormal Bone Anatomy and Physiology
Clarke, B. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04151206 · Cited by 2,192
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
Seeman, E., & Delmas, P. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra053077 · Cited by 2,080
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Takayanagi, H. (2007) · Nature Reviews Immunology · doi:10.1038/nri2062 · Cited by 1,878 · cited 2×
“Together, these factors promote the activation of transcription factors [81, 82] and gene expression in osteoclasts [83, 84].”
BackgroundFunctions of RANKL/RANK/OPG in bone modeling and remodeling
Boyce, B. F., & Xing, L. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.018 · Cited by 1,844 · cited 1×
“On the other hand, another factor called osteoprotegerin (OPG), which is produced by a wide range of cells including osteoblasts, stromal cells, and gingival and periodontal fibroblasts [87–89], binds to RANKL, preventing the RANK/RANKL interaction and, consequently, inhibiting the osteoclastogenesis [87] (Figure 5).”
Background
Research works printed but not linked: 15
- 2004, Histology and Histopathology, 19, 1325
- 1998, The nature of the mineral phase in bone, 23
- 1990, Bone-forming cells in clinical conditions, 351
- 1989, Scanning Microscopy, 3, 953
- 2000, Journal of Rehabilitation Research and Development, 37, 189
- 1999, The FASEB Journal, 13, S101
- 1999, Laboratory Investigation, 79, 83
- 2008, Journal of Musculoskeletal Neuronal Interactions, 8, 204
- 2005, Journal of Musculoskeletal Neuronal Interactions, 5, article 316
- 1972, Bone resorption and matrix hexosamine labeling, 327
- 2008, Integrins and adhesion molecules, 385
- 2004, Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 278, 505
- 2002, BMC Musculoskeletal Disorders, 7, 3
- 1997, Endocrine Society Journals and Publications, 82, 3128
- 2006, Journal of Musculoskeletal Neuronal Interactions, 6, 354
Cited by
Items 301–400 of 1,003
Biomaterials-assisted spheroid engineering for regenerative therapy
Lee, N., Bayaraa, O., Zechu, Z., & Kim, H. S. (2021) · BMB Reports · doi:10.5483/bmbrep.2021.54.7.059 · Cited by 54
Biomimetic Implant Surfaces and Their Role in Biological Integration—A Concise Review
Cruz, M., Silva, N., Marques, J. R. O. F., Mata, A., Silva, F. S., & Caramês, J. (2022) · Biomimetics · doi:10.3390/biomimetics7020074 · Cited by 54
Nanomaterials in Bone Regeneration
Babuška, V., Kasi, P. B., Chocholata, P. K., Wiesnerová, L., Dvořáková, J., Vrzáková, R., Nekleionova, A., Landsmann, L., & Kulda, V. (2022) · Applied Sciences · doi:10.3390/app12136793 · Cited by 54
Cathepsin K: A Versatile Potential Biomarker and Therapeutic Target for Various Cancers
Qian, D., He, L., Zhang, Q., Li, W., Tang, D., Wu, C., Yang, F., Li, K., & Zhang, H. (2022) · Current Oncology · doi:10.3390/curroncol29080471 · Cited by 54
Synthetic polymers as bone engineering scaffold
Javid‐Naderi, M. J., Behravan, J., Karimi‐Hajishohreh, N., & Toosi, S. (2023) · Polymers for Advanced Technologies · doi:10.1002/pat.6046 · Cited by 53
Epigenetic regulation of bone remodeling and bone metastasis
Sharma, G., Sultana, A., Abdullah, K. M., Pothuraju, R., Nasser, M. W., Batra, S. K., & Siddiqui, J. A. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.11.002 · Cited by 53
Bone cells and their role in physiological remodeling
Maciel, G. B. M., Maciel, R. M., & Danesi, C. C. (2023) · Molecular Biology Reports · doi:10.1007/s11033-022-08190-7 · Cited by 53
Osteoporosis and autophagy: What is the relationship?
Florencio‐Silva, R., Sasso, G. R. D. S., Simões, M. D. J., Simões, R. S., Baracat, M. C. P., Sasso‐Cerri, E., & Cerri, P. S. (2017) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.63.02.173 · Cited by 53
Self-citationAssociation Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone
Axelsson, K. F., Nilsson, A. G., Wedel, H., Lundh, D., & Lorentzon, M. (2017) · JAMA · doi:10.1001/jama.2017.8040 · Cited by 53
The bone anabolic effects of irisin are through preferential stimulation of aerobic glycolysis
Zhang, D., Bae, C., Lee, J., Lee, J., Jin, Z., Kang, M., Cho, Y.-S., Kim, J.-H., Lee, W., & Lim, S.-K. (2018) · Bone · doi:10.1016/j.bone.2018.05.013 · Cited by 53
Micropathological Chip Modeling the Neurovascular Unit Response to Inflammatory Bone Condition
Neto, E., Monteiro, A. C., Pereira, C. L., Simões, M., Conde, J. P., Chu, V., Sarmento, B. F. C. C., & Lamghari, M. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102305 · Cited by 53
Self-citationOsteochondral Interface: Regenerative Engineering and Challenges
Yıldırım, N., Amanzhanova, A., Kulzhanova, G., Mukasheva, F., & Erişken, C. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c01321 · Cited by 52
Nandy, A., Helderman, R. C. M., Thapa, S., Jayapalan, S., Richards, A., Narayani, N. A., Czech, M., Rosen, C. J., & Rendina-Ruedy, E. (2023) · Bone Research · doi:10.1038/s41413-023-00297-2 · Cited by 52
Flow-induced mechanotransduction in skeletal cells
Alfieri, R. R., Vassalli, M., & Viti, F. (2019) · Biophysical Reviews · doi:10.1007/s12551-019-00596-1 · Cited by 53
Walallawita, U. S., Wolber, F. M., Ziv‐Gal, A., Kruger, M. C., & Heyes, J. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197119 · Cited by 52
Skeletal energy homeostasis: a paradigm of endocrine discovery
Suchacki, K. J., Roberts, F. L., Lovdel, A., Farquharson, C., Morton, N. M., MacRae, V. E., & Cawthorn, W. P. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0147 · Cited by 51
Sartawi, Z., Schipani, E., Ryan, K. B., & Waeber, C. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.08.013 · Cited by 51
Lanthanides and tissue engineering strategies for bone regeneration
Wieszczycka, K., Staszak, K., Woźniak-Budych, M., & Jurga, S. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.03.003 · Cited by 51
The Emerging Role of MicroRNAs in Bone Diseases and Their Therapeutic Potential
Bravo-Vázquez, L. A., Becerril, M. Y. M., Hernández, E. O. M., Carmona, G. G. D. L., Padilla, M. E. A., Chakraborty, S., Bandyopadhyay, A., & Paul, S. (2021) · Molecules · doi:10.3390/molecules27010211 · Cited by 51
The Role of Inflammation in Breast and Prostate Cancer Metastasis to Bone
Göbel, A., Dell'Endice, S., Jaschke, N., Pählig, S., Shahid, A., Hofbauer, L. C., & Rachner, T. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105078 · Cited by 50
Hereditary Metabolic Bone Diseases: A Review of Pathogenesis, Diagnosis and Management
Charoenngam, N., Nasr, A., Shirvani, A., & Holick, M. F. (2022) · Genes · doi:10.3390/genes13101880 · Cited by 50
Liang, W., Zhou, C., Liu, X., Xie, Q., Xia, L., Liu, L., Bao, W., Lin, H., Xiong, X., Zhang, H., et al. (2025) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2024.12.006 · Cited by 49
da Fonseca, T. S., Silva, G. F., Guerreiro‐Tanomaru, J. M., Delfino, M. M., Sasso‐Cerri, E., Tanomaru‐Filho, M., & Cerri, P. S. (2018) · Clinical Oral Investigations · doi:10.1007/s00784-018-2550-7 · Cited by 49
Self-citationImpact of Induced Pluripotent Stem Cells in Bone Repair and Regeneration
Rana, D., Kumar, S., Webster, T. J., & Ramalingam, M. (2019) · Current Osteoporosis Reports · doi:10.1007/s11914-019-00519-9 · Cited by 49
Applications of Polymeric Composites in Bone Tissue Engineering and Jawbone Regeneration
Fraile‐Μartinez, O., Montero, C. G., Coca, A., Álvarez-Mon, M. Á., Monserrat, J., Gomez-Lahoz, A. M., Coca, S., Álvarez‐Mon, M., Acero, J., Buján, J., et al. (2021) · Polymers · doi:10.3390/polym13193429 · Cited by 49
Therapeutic Treatments for Osteoporosis—Which Combination of Pills Is the Best among the Bad?
Tonk, C. H., Shoushrah, S. H., Babczyk, P., Khaldi-Hansen, B. E., Schulze, M., Herten, M., & Tobiasch, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031393 · Cited by 49
The fabrication of the chitosan-based bioink for in vitro tissue repair and regeneration: A review
Zhang, X., Feng, C., Islam, M. R., & Li, H. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128504 · Cited by 48
Protocol for engineering bone organoids from mesenchymal stem cells
Wang, J., Zhou, D., Li, R., Sheng, S., Li, G., Sun, Y. L., Wang, P., Mo, Y., Liu, H., Chen, X., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.11.017 · Cited by 48
A Multidisciplinary Journey towards Bone Tissue Engineering
Pedrero, S. G., Llamas, P., & Serrano‐López, J. (2021) · Materials · doi:10.3390/ma14174896 · Cited by 48
Modelling acute myeloid leukemia (AML): What’s new? A transition from the classical to the modern
Dozzo, A., Galvin, A., Shin, J., Scalia, S., O’Driscoll, C. M., & Ryan, K. B. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01189-4 · Cited by 48
Hirayama, J., Hattori, A., Takahashi, A., Furusawa, Y., Tabuchi, Y., Shibata, M., Nagamatsu, A., Yano, S., Maruyama, Y., Matsubara, H., et al. (2022) · Journal of Pineal Research · doi:10.1111/jpi.12834 · Cited by 48
Zhang, S., Liao, X., Chen, S., Qian, W., Li, M., Xu, Y., Yang, M., Li, X., Mo, S., Tang, M., et al. (2022) · Advanced Science · doi:10.1002/advs.202201974 · Cited by 47
On, S.-W., Park, S., Yi, S.-M., Park, I. Y., Byun, S., & Yang, B. (2023) · Bioengineering · doi:10.3390/bioengineering10091005 · Cited by 47
The Case for Adjunctive Monoclonal Antibody Immunotherapy in Schizophrenia
Miller, B. J., & Buckley, P. F. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2016.01.003 · Cited by 47
Modulation of Osteoclast Interactions with Orthopaedic Biomaterials
Steffi, C., Shi, Z., Kong, C. H., & Wang, W. (2018) · Journal of Functional Biomaterials · doi:10.3390/jfb9010018 · Cited by 47
Kanniyappan, H., Ponrasu, T., Chakraborty, S., Arige, V., & Muthuvijayan, V. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.12.012 · Cited by 47
Costantini, A., Mäkitie, R. E., Hartmann, M. A., Fratzl‐Zelman, N., Zillikens, M. C., Kornak, U., Søe, K., & Mäkitie, O. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4668 · Cited by 47
Liu, F., Ding, Y., Xu, Z., Hao, X., Pan, T., Miles, G. E., Wang, S., Wu, Y.-H., Liu, J., Bado, I., et al. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100888 · Cited by 46
Traditional Chinese medicine promotes bone regeneration in bone tissue engineering
Gao, Z., Feng, Y., Zhao, Y., Zhao, J., Zhou, Y., Ye, Q., Chen, Y., Tan, L., Zhang, S., Feng, Y., et al. (2022) · Chinese Medicine · doi:10.1186/s13020-022-00640-5 · Cited by 46
A review on in vitro / in vivo response of additively manufactured Ti–6Al–4V alloy
Alipour, S., Nour, S., Attari, S., Mohajeri, M., Kianersi, S., Taromian, F., Khalkhali, M., Aninwene, G. E., & Tayebi, L. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb01616h · Cited by 46
Application of Hydrogels as Sustained-Release Drug Carriers in Bone Defect Repair
Feng, Y., Guo, W., Hu, L., Yi, X., & Tang, F. (2022) · Polymers · doi:10.3390/polym14224906 · Cited by 46
Effects of Exercise or Mechanical Stimulation on Bone Development and Bone Repair
Song, L. (2022) · Stem Cells International · doi:10.1155/2022/5372229 · Cited by 45
A Review of Surgical Bone Drilling and Drill Bit Heat Generation for Implantation
Islam, M. A., Kamarrudin, N. S., Daud, R., Noor, S. N. F. M., Azmi, A. I., & Razlan, Z. M. (2022) · Metals · doi:10.3390/met12111900 · Cited by 45
Circadian Regulation of Bone Remodeling
Kikyo, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094717 · Cited by 45
Ariffin, S. H. Z., Wahab, R. M. A., Razak, M. A., Yazid, M. D., Shahidan, M. A., Miskon, A., & Abidin, I. Z. Z. (2024) · PeerJ · doi:10.7717/peerj.17790 · Cited by 45
Osteogenesis and Bone Regeneration
Yang, H. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73955 · Cited by 45
Shear Stress Modulates Osteoblast Cell and Nucleus Morphology and Volume
Jin, J., Jaspers, R. T., Wu, G., Korfage, J. A. M., Klein‐Nulend, J., & Bakker, A. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218361 · Cited by 45
The molecular etiology and treatment of glucocorticoid-induced osteoporosis
Peng, C.-H., Lin, W.-Y., Yeh, K., Chen, I., Wu, W., & Lin, M. (2021) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_233_20 · Cited by 45
Microsphere‐containing Hydrogel Scaffolds for Tissue Engineering
Zhang, S., Lin, A., Tao, Z., Fu, Y., Xiao, L., Ruan, G., & Li, Y. (2022) · Chemistry - An Asian Journal · doi:10.1002/asia.202200630 · Cited by 45
Hao, D., Liu, R., Gonzalez‐Fernandez, T., Pivetti, C. D., Jackson, J. E., Kulubya, E. S., Jiang, H.-J., Ju, H.-Y., Liu, W., Panitch, A., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.05.027 · Cited by 44
Priya, P. S., Nandhini, P. P., & Arockiaraj, J. (2023) · Environmental Research · doi:10.1016/j.envres.2023.117103 · Cited by 44
León-Oliva, D. D., Boaru, D. L., Perez-Exposito, R. E., Fraile‐Μartinez, O., Montero, C. G., Díaz, R., Buján, J., García‐Honduvilla, N., López-González, L., Álvarez‐Mon, M., et al. (2023) · Gels · doi:10.3390/gels9110885 · Cited by 44
Walejewska, E., Melchels, F. P. W., Paradiso, A., McCormack, A., Szlązak, K., Olszewska, A., Srebrzynski, M., & Święszkowski, W. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.3c00909 · Cited by 44
Shokoohmand, A., Ren, J., Baldwin, J., Atack, A., Shafiee, A., Theodoropoulos, C., Wille, M., Tran, P. A., Bray, L. J., Smith, D. S., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119402 · Cited by 44
Aberrant BMP2 Signaling in Patients Diagnosed with Osteoporosis
Durbano, H. W., Halloran, D. R., Nguyen, J., Stone, V., McTague, S., Eskander, M. S., & Nohe, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186909 · Cited by 44
Midha, S., Jain, K. G., Bhaskar, N., Kaur, A., Rawat, S. J., Giri, S., Basu, B., & Mohanty, S. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0385 · Cited by 44
Kazimierczak, P., Wessely‐Szponder, J., Pałka, K., Barylyak, A., Zіnchenko, V. F., & Przekora, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065576 · Cited by 44
Composite Cryogel with Polyelectrolyte Complexes for Growth Factor Delivery
Sultankulov, B., Berillo, D. A., Kauanova, S., Mikhalovsky, S. V., Mikhalovska, L. I., & Saparov, A. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11120650 · Cited by 43
Training Young Horses: The Science behind the Benefits
Logan, A. A., & Nielsen, B. D. (2021) · Animals · doi:10.3390/ani11020463 · Cited by 43
Fracture Healing Research—Shift towards In Vitro Modeling?
Pfeiffenberger, M., Damerau, A., Lang, A., Buttgereit, F., Hoff, P., & Gaber, T. (2021) · Biomedicines · doi:10.3390/biomedicines9070748 · Cited by 43
Immune response against the biomaterials used in 3D bioprinting of organs
Elalouf, A. (2021) · Transplant Immunology · doi:10.1016/j.trim.2021.101446 · Cited by 43
Role of the Myokine Irisin on Bone Homeostasis: Review of the Current Evidence
Kornel, A., Hartogh, D. J. D., Klentrou, P., & Tsiani, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179136 · Cited by 43
Layered double hydroxide-based nanocomposite scaffolds in tissue engineering applications
İzbudak, B., Çeçen, B., Anaya, I., Miri, A. K., Bal‐Öztürk, A., & Karaöz, E. (2021) · RSC Advances · doi:10.1039/d1ra03978d · Cited by 43
Yılmaz, P., Er, E. Ö., Bakırdere, S., Ülgen, K. Ö., & Özbek, B. (2019) · Journal of Materials Research and Technology · doi:10.1016/j.jmrt.2019.08.043 · Cited by 42
Shi, W., Que, Y., Zhang, X., Bian, L., Yu, X., Xue Ming, T. A. N. G., Yang, G., Dai, Y., Bi, S., Lv, D., et al. (2021) · NPG Asia Materials · doi:10.1038/s41427-021-00297-w · Cited by 42
Rodrigues, J., Sarmento, B. F. C. C., & Pereira, C. L. (2022) · In vitro models · doi:10.1007/s44164-022-00008-x · Cited by 42
An overview of translational research in bone graft biomaterials
Kumawat, V. S., Bandyopadhyay‐Ghosh, S., & Ghosh, S. B. (2022) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2022.2127143 · Cited by 42
Pierrefite‐Carle, V., Santucci‐Darmanin, S., Breuil, V., Gritsaenko, T., Vidaud, C., Creff, G., Solari, P. L., Pagnotta, S., Al-Sahlanee, R., Auwer, C. D., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1833-5 · Cited by 42
Loss of p53 compensates osteopenia in murine Mysml deficiency
Haffner‐Luntzer, M., Kovtun, A., Fischer, V., Prystaz, K., Hainzl, A., Kroeger, C. M., Krikki, I., Brinker, T. J., Ignatius, A. A., & Gatzka, M. (2017) · The FASEB Journal · doi:10.1096/fj.201700871r · Cited by 41
Normal bone physiology, remodelling and its hormonal regulation
Mallorie, A., & Shine, B. S. F. (2022) · Surgery (Oxford) · doi:10.1016/j.mpsur.2021.12.001 · Cited by 41
Advances in hydrogels for the treatment of periodontitis
Zheng, H., Zhou, Y., Zheng, Y., & Liu, G. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb00835e · Cited by 41
Sebastian, A., Hum, N. R., Hudson, B. D., & Loots, G. G. (2015) · Microarrays · doi:10.3390/microarrays4040503 · Cited by 41
Coletta, B. B. D., Jacob, T. B., Moreira, L. A. D. C., Pomini, K. T., Buchaim, D. V., Eleutério, R. G., Pereira, E. D. S. B. M., Roque, D. D., Rosso, M. P. D. O., Shindo, J. V. T. C., et al. (2021) · Molecules · doi:10.3390/molecules26040847 · Cited by 41
Crous, A., & Abrahamse, H. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10142-w · Cited by 41
The KDM4B–CCAR1–MED1 axis is a critical regulator of osteoclast differentiation and bone homeostasis
Yi, S.-J., Jang, Y.-J., Kim, H., Lee, K., Lee, H.-R., Kim, Y., Kim, J., Hwang, S. Y., Song, J. S., Okada, H., et al. (2021) · Bone Research · doi:10.1038/s41413-021-00145-1 · Cited by 41
Pillai, S. M., Sereda, N. H., Hoffman, M. L., Valley, E. V., Crenshaw, T. D., Park, Y., Lee, J., Zinn, S. A., & Govoni, K. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168382 · Cited by 41
Cowden, K., Dias-Netipanyj, M. F., & Popat, K. C. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.01.008 · Cited by 40
Żurek, A., Mizerska-Kowalska, M., Sławińska-Brych, A., Kaławaj, K., Bojarska-Junak, A. A., Kandefer‐Szerszeń, M., & Zdzisińska, B. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.04.024 · Cited by 40
Ferreira, S. A., Young, G. R., Jones, J. R., & Rankin, S. M. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111393 · Cited by 40
Preventing tumor progression to the bone by induced tumor-suppressing MSCs
Sun, X., Li, K., Zha, R., Liu, S., Fan, Y., Wu, D., Hase, M., Aryal, U. K., Lin, C., Li, B., et al. (2021) · Theranostics · doi:10.7150/thno.58779 · Cited by 40
The role of melatonin in bone regeneration: A review of involved signaling pathways
Malakoti, F., Zare, F., Zarezadeh, R., Sadigh, A. R., Sadeghpour, A., Majidinia, M., Yousefi, B., & Alemi, F. (2022) · Biochimie · doi:10.1016/j.biochi.2022.08.008 · Cited by 40
Groenendijk, I., Grootswagers, P., Santoro, A., Franceschi, C., Bazzocchi, A., Meunier, N., Caillé, A., Malpuech‐Brugère, C., Białecka-Dębek, A., Pietruszka, B., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13111 · Cited by 40
A review: In vivo studies of bioceramics as bone substitute materials
Al‐allaq, A. A., & Kashan, J. S. (2022) · Nano Select · doi:10.1002/nano.202200222 · Cited by 40
In Vitro Evaluation of Ag- and Sr-Doped Hydroxyapatite Coatings for Medical Applications
Ungureanu, E., Vlădescu, A., Pârău, A. C., Mitran, V., Cîmpean, A., Tarcolea, M., Vrânceanu, D. M., & Cotruț, C. M. (2023) · Materials · doi:10.3390/ma16155428 · Cited by 40
Wang, K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1446536 · Cited by 39
Xin, X.-Z., Wu, J., Zheng, A., Jiao, D., Liu, Y., Cao, L., & Jiang, X. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s193544 · Cited by 39
Wu, Y. S., Jiang, Y., Liu, Q., & Liu, C. (2019) · BMC Molecular and Cell Biology · doi:10.1186/s12860-019-0230-3 · Cited by 39
Oustadi, F., Imani, R., Nazarpak, M. H., & Sharifi, A. M. (2020) · Polymers for Advanced Technologies · doi:10.1002/pat.4905 · Cited by 39
Ehnert, S., Rinderknecht, H., Aspera-Werz, R. H., Häussling, V., & Nussler, A. K. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02906-z · Cited by 39
Tamura, T., Yoshioka, Y., Sakamoto, S., Ichikawa, T., & Ochiya, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186680 · Cited by 39
Sharma, A., Sharma, L. K., & Goyal, R. (2020) · Current Drug Targets · doi:10.2174/1389450121666200910160404 · Cited by 39
An insight into cell-laden 3D-printed constructs for bone tissue engineering
Swetha, S. V., Lavanya, K., Sruthi, R., & Selvamurugan, N. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb02019b · Cited by 39
MicroRNAs regulating TGFβ and BMP signaling in the osteoblast lineage
Garcia, J., & Delany, A. M. (2020) · Bone · doi:10.1016/j.bone.2020.115791 · Cited by 39
Yan, F., Wang, W.-C., & Cheng, H. W. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.09.017 · Cited by 39
Emam, S. M., & Moussa, N. (2024) · BDJ Open · doi:10.1038/s41405-024-00211-w · Cited by 38
Lyu, Z., Yuan, G., Zhang, Y., Zhang, F., Liu, Y., Li, Y., Li, G., Wang, Y., Zhang, M., Hu, Y., et al. (2024) · Microbiome · doi:10.1186/s40168-024-01920-y · Cited by 38
Innate immune response to bone fracture healing
Burgan, J., Rahmati, M., Lee, M., & Saiz, A. M. (2024) · Bone · doi:10.1016/j.bone.2024.117327 · Cited by 38
Immunomodulatory and Regenerative Functions of MSC-Derived Exosomes in Bone Repair
Arun, M., Rajasingh, S., Parani, M., & Rajasingh, J. (2025) · Bioengineering · doi:10.3390/bioengineering12080844 · Cited by 38
Wang, Y., Wang, K., Zhang, L., Tan, Y., Hu, Z., Dang, L., Zhou, H., Li, G., Wang, H., Zhang, S., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2325-3 · Cited by 38
Advances in Sensing Technologies for Monitoring of Bone Health
Rani, S., Bandyopadhyay‐Ghosh, S., Ghosh, S. B., & Liu, G. (2020) · Biosensors · doi:10.3390/bios10040042 · Cited by 38
Metadata
- Authors
- Florencio-Silva, R., Sasso, G. R. D. S., Sasso-Cerri, E., Simões, M. J., & Cerri, P. S.
- Affiliations
- Department of Morphology and Genetics, Laboratory of Histology and Structural Biology, Federal University of São Paulo, 04023-900 São Paulo, SP, Brazil
- Universidade Federal de São Paulo (BR)
- Department of Morphology, Laboratory of Histology and Embryology, Dental School, Universidade Estadual Paulista (UNESP), 14801-903 Araraquara, SP, Brazil
- Universidade Estadual Paulista (Unesp) (BR)
- Corresponding author
- Cerri, Paulo Sérgio
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-17
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4515490
- OpenAlex
- W1594526962
- Cited by
- 2,044
- References
- 209
- Citations by year
- 2026: 157 · 2025: 238 · 2024: 265 · 2023: 286 · 2022: 254 · 2021: 241 · 2020: 219 · 2019: 169 · 2018: 110 · 2017: 64 · 2016: 35 · 2015: 5
- FWCI
- 6.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Americanae (AECID Library) (publishedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Acervo Digital da Universidade Estadual Paulista (Universidade Estadual Paulista) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2010/10391-9, 2012/19428-8, 2012/22666-8)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (2010/10391-9, 2012/19428-8, 2012/22666-8)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (2010/10391-9, 2012/19428-8, 2012/22666-8)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
- Keywords
- bone remodeling, bone cells, osteoclasts, osteoblasts, osteocytes, bone resorption, bone formation, bone homeostasis, osteocyte apoptosis, osteoporosis, calcitonin, estrogen, growth factors, cytokines, mechanosensing, intercellular communication
- MeSH terms
- Animals, Bone and Bones, Calcification, Physiologic, Cell Communication, Humans, Models, Biological, Osteoblasts, Osteoclasts, Structure-Activity Relationship, Bone Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.